Abstract
Vaccine studies in psychoneuroimmunology (PNI) provide an insight into biopsychosocial interactions and their role in infectious diseases. How to measure vaccine responses is therefore of critical importance for PNI researchers. In this chapter, traditional and modern immunoassays for the assessment of vaccine responses are discussed, highlighting how modern multiplex techniques provide researchers with greater capacity and opportunity for novel research relating to vaccine outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Note that due to the variability in the real-world exposure to viral particles, it is not possible to truly say that an individual is protected from infection based on antibody levels. Rather, protection estimates are probabilistic.
References
Vedhara K, Cox NK, Wilcock GK et al (1999) Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353:627–631
Glaser R, Sheridan J, Malarkey WB et al (2000) Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom Med 62:804–807
Hayney MS, Coe C, Muller D et al (2014) Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial. Hum Vaccin Immunother 10:2759–2767
Ayling K, Fairclough L, Tighe P et al (2018) Positive mood on the day of influenza vaccination predicts vaccine effectiveness: a prospective observational cohort study. Brain Behav Immun 67:314–323. https://doi.org/10.1016/j.bbi.2017.09.008
Phillips A (2012) The vaccination model in psychoneuroimmunology research: a review. In: Yan Q (ed) Psychoneuroimmunology: methods and protocols. Springer Science & Business Media, LLC, Santa Clara, CA, pp 355–370
Burns VE, Gallagher S (2010) Antibody response to vaccination as a marker of in vivo immune function in psychophysiological research. Neurosci Biobehav Rev 35:122–126
Chen W, Kozlovsky B, Effros R (2009) Vaccination in the elderly: an immunological perspective. Trends Immunol 30:351–359
Woods JA, Keylock KT, Lowder T et al (2009) Cardiovascular exercise training extends influenza vaccine seroprotection in sedentary older adults: the immune function intervention trial. J Am Geriatr Soc 57:2183–2191
Edwards KM, Burns VE, Reynolds T et al (2006) Acute stress exposure prior to influenza vaccination enhances antibody response in women. Brain Behav Immun 20:159–168
Vedhara K, Bennett PD, Clark S et al (2003) Enhancement of antibody responses to influenza vaccination in the elderly following a cognitive-behavioural stress management intervention. Psychother Psychosom 72:245–252
Siegrist C (2012) Vaccine immunology. In: Plotkin S, Orenstein W, Offit P (eds) Vaccines, 6th edn. Elsevier Inc., Amsterdam, pp 17–36
McElhaney JE, Ewen C, Zhou X et al (2009) Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 27:2418–2425
McElhaney JE, Xie D, Hager WD et al (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176:6333–6339
Lange T, Dimitrov S, Bollinger T et al (2011) Sleep after vaccination boosts immunological memory. J Immunol 187:283–290
Leng SX, McElhaney JE, Walston JD et al (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63:879–884
Pedersen J (2014) Hemagglutination-Inhibition Assay for Influenza Virus Subtype Identification and the Detection and Quantitation of Serum Antibodies to Influenza Virus. In: Spackman E (ed) Animal influenza virus, methods in molecular biology. Springer Science & Business Media, LLC, New York, pp 11–25
Hobson D, Curry RL, Beare AS et al (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70:767–777
de Jong JC, Palache AM, Beyer WEP et al (2003) Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 115:63–73
Coudeville L, Bailleux F, Riche B et al (2010) Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol 10:18
Segerstrom S, Smith G (2012) Methods, variance, and error in psychoneuroimmunology research: the good, the bad, and the ugly. In: Segerstrom S (ed) The Oxford handbook of psychoneuroimmunology. Oxford University Press, New York, pp 421–432
Chang T (1983) Binding of cells to matrixes of distinct antibodies coated on solid surface. J Immunol Methods 65:217–223
Shena M, Shalon D, Davis RW et al (1995) Quantitative monitoring of gene expression patterns with a complimentary DNA microarray. Science 270:467–470
Jiang H, Deng Y, Chen H et al (2004) Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinfomatics 5:1–12
Negm OH, Hamed MR, Dilnot EM et al (2015) Profiling humoral immune responses to clostridium difficile-specific antigens by protein microarray analysis. Clin Vacc Immunol 22:1033–1039
Selvarajah S, Negm OH, Hamed MR et al (2014) Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera. Mediators Inflamm 2014:820304
Tighe P, Ryder RR, Todd I et al (2015) ELISA in the multiplex era: potentials and pitfalls. Proteomics Clin Appl 9:406–422
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ayling, K., Vedhara, K., Fairclough, L. (2018). Measuring Vaccine Responses in the Multiplex Era. In: Yan, Q. (eds) Psychoneuroimmunology. Methods in Molecular Biology, vol 1781. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7828-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7828-1_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7827-4
Online ISBN: 978-1-4939-7828-1
eBook Packages: Springer Protocols